{
    "title": "Loxo, Bayer to co-develop cancer drugs in up to $1.55 bln deal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5081243/Loxo-Bayer-develop-cancer-drugs-1-55-bln-deal.html",
    "date": "2017-11-14",
    "keywords": [
        "bayer",
        "cancer",
        "drug",
        "year",
        "deal",
        "loxo",
        "oncology",
        "percent",
        "development",
        "larotrectinib",
        "field",
        "treatment",
        "reporting",
        "stamford",
        "premarket",
        "trading",
        "upfront",
        "milestone",
        "followon",
        "compound",
        "loxo195",
        "belong",
        "class",
        "trk",
        "point",
        "attack",
        "breakthrough",
        "precision",
        "medicine",
        "profile",
        "monsanto",
        "slump",
        "bestselling",
        "xarelto",
        "patent",
        "protection",
        "merck",
        "amp",
        "cos",
        "immunotherapy",
        "keytruda",
        "regardless",
        "body",
        "disease",
        "file",
        "commercialization",
        "approval",
        "tamara",
        "burger",
        "frankfurt",
        "editing",
        "sai",
        "sachin",
        "ravikumar"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}